<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04828733</url>
  </required_header>
  <id_info>
    <org_study_id>OAGB/FUNDO</org_study_id>
    <nct_id>NCT04828733</nct_id>
  </id_info>
  <brief_title>Laparoscopic Gastric Bypass With the Total Wrapping of the Fundus of Gastric Excluded Part for Treating Obesity and GERD</brief_title>
  <official_title>A Randomized Controlled Trial of Laparoscopic One Anastomosis Gastric Bypass (OAGB) With the Cruroraphy and Total Wrapping of the Fundus of Gastric Excluded Part Versus OAGB With Only Hiatus Cruroraphy for Treating Morbid Obesity and GERD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Society of Bariatric and Metabolic Surgeons of Kazakhstan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Society of Bariatric and Metabolic Surgeons of Kazakhstan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background and study aims:&#xD;
&#xD;
      Currently, one anastomosis Gastric Bypass/Mini Gastric Bypass (OAGB/MGB) is a common&#xD;
      bariatric procedure.&#xD;
&#xD;
      Obesity and gastroesophageal reflux disease are steadily increasing world weight and&#xD;
      antireflux surgery must be performed simultaneously with bariatric surgery in obese patients.&#xD;
      In these cases, most often, hiatus cruroraphy is performed, and less often fundoplication&#xD;
      using the fundus of the excluded part of the stomach. We hypothesize that total&#xD;
      fundoplication can not only treat GERD but also prevent the return of weight like a banded&#xD;
      gastric bypass.&#xD;
&#xD;
      The aim study is to compare bariatric and antireflux results after OAGB/MGB plus suture&#xD;
      cruroplasty (SCP) with and without total fundoplication.&#xD;
&#xD;
      Methods: Adult participants (n=100) are randomly allocated to one of two groups:&#xD;
&#xD;
      Experimental surgical bariatric procedure in the first (A) group: patients (n=50) undergo the&#xD;
      laparoscopic one anastomosis gastric bypass with the total wrapping of the fundus of gastric&#xD;
      excluded part and suture cruroplasty (OAGB + SCP + TF group); Active comparator surgical&#xD;
      bariatric procedure in the second (B) group: patients (n=50) undergo the laparoscopic one&#xD;
      anastomosis gastric bypass with only suture cruroplasty (OAGB + SCP group). All patients are&#xD;
      then followed up 12, 24, 36 months after surgery where record the changing body mass index&#xD;
      and change of GERD symptoms (GERD-HRQL).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One anastomosis Gastric Bypass/Mini Gastric Bypass (OAGB/MGB) is gaining popularity as a&#xD;
      primary surgical treatment for morbid obesity. The total fundoplication is the gold standard&#xD;
      for treating GERD. Morbid obesity and GERD require simultaneous surgical treatment. We&#xD;
      hypothesize that total fundoplication can not only treat GERD but also prevent the return of&#xD;
      weight like a banded gastric bypass.&#xD;
&#xD;
      The aim study is to compare bariatric and antireflux results after OAGB/MGB plus suture&#xD;
      cruroplasty (SCP) with and without total fundoplication.&#xD;
&#xD;
      Adult participants (n=100) are randomly allocated to one of two groups:&#xD;
&#xD;
      Experimental surgical bariatric procedure in the first (A) group: patients (n=50) undergo the&#xD;
      laparoscopic one anastomosis gastric bypass with the total wrapping of the fundus of gastric&#xD;
      excluded part and suture cruroplasty (OAGB + SCP + TF group); Active comparator surgical&#xD;
      bariatric procedure in the second (B) group: patients (n=50) undergo the laparoscopic one&#xD;
      anastomosis gastric bypass with only suture cruroplasty (OAGB + SCP group). All patients are&#xD;
      then followed up 12, 24, 36 months after surgery where record the changing body mass index&#xD;
      and change of GERD symptoms (GERD-HRQL).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 29, 2021</start_date>
  <completion_date type="Anticipated">May 10, 2024</completion_date>
  <primary_completion_date type="Anticipated">April 5, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of body mass index</measure>
    <time_frame>Baseline, at 12, 24, 36 months after surgery</time_frame>
    <description>The measure is assessing a change of body mass index. Weight (kg) and height (cm) will be combined with the report of measurement by body mass index (BMI) kg/m2.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of GERD symptoms (GERD-HRQL)</measure>
    <time_frame>12, 24, 36 months after surgery</time_frame>
    <description>Success; â‰¥50% improvement in the baseline GERD-HRQL score Failure; &lt;50% improvement in the baseline GERD-HRQL score at 12,24, 36 months.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Obesity</condition>
  <condition>GERD</condition>
  <arm_group>
    <arm_group_label>Antireflux OAGB group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Antireflux laparoscopic one anastomosis gastric bypass with suture cruroplasty and the total wrapping of the fundus of the gastric excluded part.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard OAGB group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>laparoscopic one anastomosis gastric bypass with only suture cruroplasty.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Antireflux laparoscopic one anastomosis gastric bypass</intervention_name>
    <description>Laparoscopic gastric bypass with suture cruroplasty and total wrapping of the fundus of gastric excluded part.</description>
    <arm_group_label>Antireflux OAGB group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard laparoscopic one anastomosis gastric bypass</intervention_name>
    <description>laparoscopic gastric bypass with only suture cruroplasty. Not used fundoplication.</description>
    <arm_group_label>Standard OAGB group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  BMI from 30 to 50 kg / m2.&#xD;
&#xD;
          -  Gastroesophageal reflux diseases&#xD;
&#xD;
          -  The person is generally fit for anesthesia (ASA grading 1-2) and surgery.&#xD;
&#xD;
          -  The person commits to the need for long-term follow-up.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  BMI less than 30 kg / m2 and more than 50 kg / m2.&#xD;
&#xD;
          -  Prosthetic (mesh) hiatal herniorrhaphy or large hiatal hernia;&#xD;
&#xD;
          -  Esophageal shortening&#xD;
&#xD;
          -  Los Angeles Classification of Oesophagitis (LA grade) C or D reflux esophagitis&#xD;
&#xD;
          -  History of surgery on the stomach or esophagus&#xD;
&#xD;
          -  Less than 18 or more than 60 years of age&#xD;
&#xD;
          -  Not fit for bariatric surgery&#xD;
&#xD;
          -  Psychiatric illness&#xD;
&#xD;
          -  Patients unwilling or unable to provide informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oral Ospanov, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>President of Society of Bariatric and Metabolic Surgeons of Kazakhstan&quot; (SBMSK)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Oral Ospanov, Professor</last_name>
    <phone>+77015287734</phone>
    <email>bariatric.kz@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Oral Ospanov</last_name>
    <phone>+77015287734</phone>
    <email>bariatric.kz@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oral Ospanov</name>
      <address>
        <city>Astana</city>
        <zip>020000</zip>
        <country>Kazakhstan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oral Ospanov</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Kazakhstan</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 30, 2021</study_first_submitted>
  <study_first_submitted_qc>March 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2021</study_first_posted>
  <last_update_submitted>April 9, 2021</last_update_submitted>
  <last_update_submitted_qc>April 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>GERD</keyword>
  <keyword>Gastric bypass</keyword>
  <keyword>Fundoplication</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

